The 2026 LMG Life Sciences Americas Awards recognized Arnold & Porter's life sciences capabilities with two awards at its annual ceremony on September 10, 2026.
Partner Eva Temkin was named FDA Litigation & Enforcement Attorney of the Year, recognizing her work advising life sciences clients on complex FDA regulatory and enforcement matters. Drawing on nearly a decade of experience at the FDA, Eva helps clients develop and execute regulatory, legislative, and litigation strategies. She serves as lead FDA counsel on complex litigation and financial transactions and advises clients on compliance, enforcement, regulatory mandates, and FDA disputes.
The firm also received a Deal of the Year award for its representation of Boston Scientific Corporation on the antitrust aspects of its approximately $15 billion acquisition of Penumbra, Inc., the second-largest transaction in Boston Scientific's history. The matter was led by Michael Bernstein, Global Co-Chair of Arnold & Porter's Antitrust/Competition practice group.
Arnold & Porter was shortlisted in 13 additional categories. The firm's integrated life sciences team advises clients across antitrust and competition, regulatory, transactional, intellectual property, and litigation matters, including complex regulatory approvals, investigations, and litigation.